These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6262485)

  • 1. Locomotor activity and antinociception after putative mu, kappa and sigma opioid receptor agonists in the rat: influence of dopaminergic agonists and antagonists.
    Iwamoto ET
    J Pharmacol Exp Ther; 1981 May; 217(2):451-60. PubMed ID: 6262485
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A; Sorrentino L
    Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of mu- and kappa-receptors by means of correlation of analgesic potency in vivo and receptor binding affinity in vitro of various opioid agonists.
    Ensinger HA; Stockhaus K; Merz H
    Methods Find Exp Clin Pharmacol; 1984 Oct; 6(10):649-53. PubMed ID: 6096651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice.
    Mori T; Ito S; Kita T; Narita M; Suzuki T; Sawaguchi T
    Eur J Pharmacol; 2006 Feb; 532(1-2):81-7. PubMed ID: 16464448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of local intracerebral administration of EMD 57445, a selective sigma receptor ligand, on the locomotor activity of the rat.
    Skuza G; Kolasiewicz W; Dziedzicka-Wasylewska M; Margas W
    Pol J Pharmacol; 1998; 50(6):399-406. PubMed ID: 10385922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists.
    Fujii H; Watanabe A; Nemoto T; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem Lett; 2009 Jan; 19(2):438-41. PubMed ID: 19042127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system.
    Tao R; Auerbach SB
    J Pharmacol Exp Ther; 2002 Nov; 303(2):549-56. PubMed ID: 12388635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu opioid agonists potentiate amphetamine- and cocaine-induced rotational behavior in the rat.
    Kimmel HL; Holtzman SG
    J Pharmacol Exp Ther; 1997 Aug; 282(2):734-46. PubMed ID: 9262337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential stereospecific effects of mu, kappa, and sigma opioid agonists on cortical EEG power spectra in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1983 Apr; 43():190-5. PubMed ID: 6308453
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ligands of opioid and sigma receptors and correction of cardiac electrical instability in post-infarction cardiosclerosis].
    Maslov LN; Lishmanov IuB; Naryzhnaia NV; Krylatov AV; Tam SV
    Eksp Klin Farmakol; 2001; 64(1):38-41. PubMed ID: 11544802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonism of nitrous oxide antinociception in the rat hot plate test by site-specific mu and epsilon opioid receptor blockade.
    Hodges BL; Gagnon MJ; Gillespie TR; Breneisen JR; O'Leary DF; Hara S; Quock RM
    J Pharmacol Exp Ther; 1994 May; 269(2):596-600. PubMed ID: 8182525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY; Zhao M; Yuan YK; Fan GX; Jia H; Tang JS
    Neuroscience; 2006; 138(4):1319-27. PubMed ID: 16472929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for a 7-benzylidenenaltrexone-preferring opioid receptor mediating the inhibitory actions of peptidic delta- and mu-opioid agonists on neurogenic ion transport in porcine ileal mucosa.
    Poonyachoti S; Portoghese PS; Brown DR
    J Pharmacol Exp Ther; 2001 May; 297(2):672-9. PubMed ID: 11303057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
    Schmauss C; Yaksh TL
    J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic naltrexone on amphetamine locomotor activity.
    Ng Cheong Ton MJ; Blair R; Holmes L; Amit Z
    Subst Alcohol Actions Misuse; 1983; 4(4):331-6. PubMed ID: 6322365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A kappa opioid effect: increased urination in the rat.
    Leander JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):89-94. PubMed ID: 6294284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.